JPRN-UMIN000006288已完成2 期
Phase II Study of Primary Chemotherapy with Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients with HER2 Positive Breast Cancer - Primary Chemotherapy with Anthracycline Followed by Nab-paclitaxel and Trastuzumab
Breast and endocrine surgery Osaka Medical College Hospital0 个研究点目标入组 45 人开始时间: 2011年9月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. With history of hypersensitivity reaction for important drug in this study 2. With history of invasive breast cancer 3. Bilateral invasive breast cancer 4. Patients with medical conditions that renders them intolerant to primary chemotherapy and related treatment, including infection, diarrhea, intestinal paralysis, severe Diabetes Mellitus 5. Positive for HBs antigen and with history of HVB 6. With history of congestive heart failure, uncontrolled or symptomatic angina pectoris, arrhythmia or myocardial infarction, poorly controlled hypertension 7. With severe edema 8. With severe peripheral neuropathy 9. With severe psychiatric disorder 10. Pregnant or nursing women 11. Cases who physician judged improper to entry this trial
研究者
相似试验
进行中（未招募）
1 期
Phase II study of up-front chemotherapy and neo-adjuvant short-course radiotherapy for resectable rectal carcinomaresectable rectal carcinomaMedDRA version: 15.1 Level: LLT Classification code 10038052 Term: Rectal carcinoma System Organ Class: 100000004864EUCTR2013-000770-30-ITIRCCS ISTITUTO SCIENTIFICO ROMAGNOLO PER LO50
已完成
2 期
Phase II study of Chemotherapy for Advanced or Recurrent ThymomaThymoma (excluding thymic carcinoma)JPRN-C000000350Japanese Association for Research on the Thymus50
已完成
2 期
A phase II study of first line chemotherapy by eribulin mesilate for HER2 negative recurrent breast cancerBreast cancerJPRN-UMIN000007990Kobe Breast Cancer Oncology Group35
已完成
1 期
Phase I / II Study of Alternating Chemotherapy with Cisplatin plus Nogitecan plus Paclitaxel (PlaTT) and Cisplatin plus Amrubicin plus Paclitaxel (PAT) for Advanced Lung Cancer PatientsAdvanced Lung CancerJPRN-UMIN000012270iigata Lung Cancer Treatment Group18
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50